Boston – September 17, 2026 -- Outcomes4Me Inc. has appointed Jim Longley, formerly Senior Vice President of AI Partnerships at OpenEvidence, as its new Chief Revenue Officer to lead commercial expansion across pharma, provider, and diagnostic partnerships.
Longley brings two decades of health tech revenue scaling to the role
Before OpenEvidence, Longley spent nearly five years at GoodRx, rising to Senior Vice President and Head of Commercial, and prior to that spent over six years at Doximity as Vice President for Business Development and Product Innovation. Outcomes4Me CEO Maya R. Said, Sc.D., said Longley has a track record of scaling health tech companies to hundreds of millions of dollars in revenue.
Outcomes4Me serves 400,000 patients and nine of the top ten oncology pharma companies
The direct-to-patient cancer platform integrates clinical guidelines, genomics, clinical trial matching, and symptom tracking. Longley's mandate is to deepen life sciences collaborations as the company enters what Said described as a phase of exponential growth.
Company posted 395% three-year growth, landing on Inc. 5000 for second consecutive year
Outcomes4Me was also recognized on the 2026 Fierce50 list, which honored CEO Maya R. Said for driving healthcare innovation, and the company was named a nominee for "Best Startup" by the Prix Galien USA program.
Clinical team integrated 10 NCCN guideline updates spanning five cancer types
The updates cover bladder, breast, kidney, non-small cell lung, and prostate cancer, ensuring platform users have access to current treatment recommendations. Separately, the San Antonio Breast Cancer Symposium selected an Outcomes4Me poster, "Are We Listening to Every Patient? Digital Tools, Patient-Reported Outcomes and Disparities in Breast Cancer," for a spotlight session scheduled for 7:00am CT on December 10, 2026.
"Outcomes4Me has proven that it can help patients living with cancer while also creating tremendous value for its pharma customers by getting their life-saving therapies to the right patient at the right time," Longley said, adding that the platform's ability to reach patients with diagnosis-level specificity was unmatched in his experience.
The Outcomes4Me team is attending Fierce Pharma Week in Philadelphia from September 14-17, 2026.